Friday, 2 June 2023

Torrent Pharmaceuticals

Revenue up 16.9% at Rs 2,491 crore (Bloomberg estimate: Rs 2,474.3 crore) Ebitda up 29.6% at Rs 727 crore (Bloomberg estimate: Rs 728.6 crore) Ebitda margin at 29.2% vs 26.3% (Bloomberg estimate: 29.4%) Net profit of Rs 287 crore vs net loss of Rs 118 crore (Bloomberg estimate: Rs 322.2 crore profit) The board approved raising Rs 5,000 crore via crore via debt. The company will pay a final dividend of Rs 8 per share for the fiscal 2023.
at

India Daybook – Stocks in News

*P&G:* Net profit up 36.5% Rs 210.7 cr, Revenue up 8.9% at Rs 1,138.4 cr YoY  *TVS Motors:* Net profit at Rs 536.6 cr vs poll Rs 520.0 c...

  • Kewal Kiran Clothing
    The company, which runs the fashion brand Killer, has entered a strategic partnership Board of Control for Cricket in India to become an off...
  • Bank of India
    The public sector lender has revised its marginal cost of fund-based lending rate (MCLR) with effect from November 1 in terms of the pricing...
  • Procter & Gamble
    he FMCG company has reported a 36 percent on-year growth in net profit at Rs 211 crore for the quarter ended September FY24 (Q1 FY24), led b...